FOMX - Foamix Pharmaceuticals Ltd. (FOMX) CEO Dave Domzalski on Q3 2019 Earnings & Merger Announcement with Menlo Therapeutics Conference (Transcript)
Foamix Pharmaceuticals Ltd. (FOMX)
Q3 2019 Earnings Conference Call
November 12, 2019 8:00 AM ET
Company Participants
Michael Wood - LifeSci Advisors
Dave Domzalski - Chief Executive Officer
Matt Wiley - Chief Commercial Officer
Steve Basta - Chief Executive Officer, Menlo Therapeutics
Conference Call Participants
Louise Chen - Cantor Fitzgerald
David Amsellem - Piper Jaffray
Ken Cacciatore - Cowen & Company
Balaji Prasad - Barclays
Jason Gerberry - Bank of America
Patrick Dolezal - LifeSci Capital
Presentation
Operator
Good morning. Welcome to the Foamix Conference Call to discuss the Merger of Foamix Pharmaceuticals with Menlo